Karban et al., 2016 - Google Patents
Programmed nanoparticles for tailoring the detection of inflammatory bowel diseases and irritable bowel syndrome disease via breathprintKarban et al., 2016
View PDF- Document ID
- 9627181596412636686
- Author
- Karban A
- Nakhleh M
- Cancilla J
- Vishinkin R
- Rainis T
- Koifman E
- Jeries R
- Ivgi H
- Torrecilla J
- Haick H
- Publication year
- Publication venue
- Adv Healthc Mater
External Links
Snippet
The rationale behind this approach relies on the fact that VOCs generated by cellular metabolic pathways [6] during a specific disease, circulate in the blood stream and diffuse into places as feces and exhaled breath, which can be clinically sampled.[7, 8] Mass …
- 206010021972 Inflammatory bowel disease 0 title abstract description 48
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/02—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the impedance of the material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Karban et al. | Programmed nanoparticles for tailoring the detection of inflammatory bowel diseases and irritable bowel syndrome disease via breathprint | |
Kalantar-Zadeh et al. | A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut | |
De Vries et al. | Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis | |
Blanchet et al. | Factors that influence the volatile organic compound content in human breath | |
Zetola et al. | Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples | |
Ahmed et al. | Exhaled volatile organic compounds of infection: a systematic review | |
Nardi-Agmon et al. | Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects | |
Binson et al. | Discrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose | |
Oakley-Girvan et al. | Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review | |
Fitzgerald et al. | Cutting edge methods for non-invasive disease diagnosis using e-tongue and e-nose devices | |
Bannier et al. | Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis | |
US20190271685A1 (en) | System and method for differential diagnosis of diseases | |
van Mastrigt et al. | Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis | |
Kumar et al. | Selective determination of ammonia, ethanol and acetone by reduced graphene oxide based gas sensors at room temperature | |
Marzorati et al. | MOS sensors array for the discrimination of lung cancer and at-risk subjects with exhaled breath analysis | |
Li et al. | Exposure to ultrafine particles and oral flora, respiratory function, and biomarkers of inflammation: A panel study in children | |
Eamsa-Ard et al. | Screening and discrimination of Hepatocellular carcinoma patients by testing exhaled breath with smart devices using composite polymer/carbon nanotube gas sensors | |
Rouvroye et al. | Faecal scent as a novel non-invasive biomarker to discriminate between coeliac disease and refractory coeliac disease: a proof of principle study | |
Xuan et al. | Engineering solutions to breath tests based on an e-nose system for silicosis screening and early detection in miners | |
Keogh et al. | The use of breath analysis in the management of lung cancer: is it ready for primetime? | |
Qin et al. | Evaluation of synovial fluid neutrophil CD64 index as a screening biomarker of prosthetic joint infection | |
Zhang et al. | The exposome in the era of the quantified self | |
Huang et al. | Application of artificial intelligence modeling technology based on multi-omics in noninvasive diagnosis of inflammatory bowel disease | |
Qian | Characteristics of extra-oral halitosis induced by functional constipation: a prospective cohort study | |
Binson et al. | Detection of early lung cancer cases in patients with COPD using eNose technology: a promising non-invasive approach |